Annovis Bio Inc (ANVS) Stock Price

0.945 ▼ -0.0543 (-5.43%)
Open: 0.98 Vol: 0 Day's range: 0.945 - 0.98 Oct 26, 10:52 EDT
IEX quote, 15 minutes delayed during trading hours. Login or Signup to see real-time data
Free Stock Screener
Loading chart ...
ANVS Technical Analysis
5 mins 30 mins Hourly Daily Weekly
SELL SELL SELL SELL SELL
  5 mins 30 mins Hourly Daily Weekly
MA5 0.96▼ 0.97▼ 0.97▼ 0.98▼ 1.07▼
MA10 0.97▼ 0.97▼ 0.97▼ 1.00▼ 1.20▼
MA20 0.97▼ 0.99▼ 0.99▼ 1.10▼ 1.50▼
MA50 1.00▼ 0.99▼ 1.00▼ 1.32▼ 2.24▼
MA100 1.00▼ 1.01▼ 1.07▼ 1.56▼ 2.46▼
MA200 1.01▼ 1.09▼ 1.15▼ 1.96▼ 6.79▼
  5 mins 30 mins Hourly Daily Weekly
MACD -0.002▼ -0.004▼ -0.004▼ -0.001▼ -0.034▼
RSI 32.858▼ 35.997▼ 37.817▼ 31.375▼ 32.507▼
STOCH 14.052▼ 33.466     23.531     11.465▼ 11.581▼
WILL %R -100.000▼ -100.000▼ -100.000▼ -100.000▼ -100.000▼
CCI -158.831▼ -187.575▼ -152.836▼ -95.002     -97.443    
Latest Filters Detected On ANVS
MA $ANVS Price Crossed Below MA(7) Set Alert
▼ BREAK $ANVS Price Breaks 60 Days Low Set Alert
▼ BREAK $ANVS Price Breaks 30 Days Low Set Alert
▼ BREAK $ANVS Price Breaks 20 Days Low Set Alert
▼ BREAK $ANVS Price Breaks 10 Days Low Set Alert
CDL $ANVS Marubozu Candlestick Pattern Detected Set Alert
Annovis Bio Inc News
Annovis to Attend the CTAD 2026 with Three Presentations
Thursday, October 22, 2026 01:00 AM
Annovis Bio, Inc. (NYSE: ANVS) (“Annovis” or the “Company”), a Phase 3 clinical-stage biotechnology company developing the investigational oral therapy, buntanetap, for neurodegenerative diseases such ...
Networknewsbreaks Annovis Bio Inc. (NYSE: ANVS) To Present Buntanetap Research And Phase 3 Trial Updates At Alzheimer Conference
Wednesday, October 21, 2026 07:10 PM
To Present Buntanetap Research And Phase 3 Trial Updates At Alzheimer Conference. Annovis Bio (NYSE: ANVS) anno ...
BioMedNewsBreaks — Annovis Bio Inc. (NYSE: ANVS) Collaborates With Weave Bio to Support Buntanetap NDA Preparation
Wednesday, September 23, 2026 07:20 AM
Annovis Bio (NYSE: ANVS) announced a collaboration with Weave Bio to support preparation of the planned New Drug Application (“NDA”) for buntanetap, its investigational oral therapy for ...
ANVS historical stock data
date open high low close volume
26/10/26 0.98 0.98 0.945 0.945 242,919
23/10/26 0.99 1.01 0.961 0.9993 315,625
22/10/26 0.99 1.05 0.98 0.9917 448,258
21/10/26 1.00 1.04 0.9878 0.9932 546,328
20/10/26 0.96 1.04 0.96 0.9783 691,834
19/10/26 0.995 1.04 0.95 0.96 641,347
16/10/26 1.06 1.08 0.987 0.9934 641,421
15/10/26 1.04 1.075 1.01 1.05 570,641
14/10/26 1.05 1.08 1.01 1.02 843,701
13/10/26 1.15 1.15 1.05 1.06 842,713
Quote Details
52wk Low:0.945
52wk High:5.50
Vol:0
Avg Vol(3m):17.3M
1Y Chng:-55.21%
1M Chng:-15.63%
Add to Watch List
More Information
Index N/A
Market Cap. 42.32M